You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK)指今年不會在資本市場融資
內媒報道,藥明康德(02359.HK)相關人士在業績會上透露,公司今年不會在資本市場進行融資,另有其他多種融資方式可滿足公司需求。 此外,相關人士指對於2019年發行的3億美元可轉債,在目前已轉股96.2%基礎上,公司將在4月初完成剩餘可轉債現金贖回。因此第二季開始淨利潤不再受可轉債公允價值波動影響。 公司於2021及2022年因可轉債衍生金融工具部分的公允價值變動,分別為虧損10.01億元人民幣(下同)和收益5.09億元。 藥明康德H股現報78.05元,升5.97%,成交102.08萬股,涉資7,859.03萬元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account